SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, ...
SAN JOSE, Calif.--(BUSINESS WIRE)-- Outset Medical, Inc. (Nasdaq: OM) (“Outset”) today announced that its Tablo® Hemodialysis System has received the first-ever approval from the Centers for Medicare ...
Tablo is an FDA-cleared enterprise solution for dialysis, designed specifically to reduce the cost and complexity of dialysis across all care settings. Requiring only an electrical outlet and tap ...
Please provide your email address to receive an email when new articles are posted on . The FDA has approved Outset Medical’s Tablo Hemodialysis System for use in a home setting after positive results ...
The Tablo System promises to make dialysis easier and more convenient for patients. But there are significant barriers to the technology. By Dawn MacKeen This article is part of Upstart, a series ...
Please provide your email address to receive an email when new articles are posted on . KANSAS CITY, Mo. — Research from two studies presented at The Annual Dialysis Conference suggested at-home use ...
Fast-growing startup Strive Health is teaming up with another disrupter in the kidney care space to expand patient access to home-based hemodialysis services. Strive Health will use Outset Medical’s ...
Outset Medical, Inc. OM recently announced that its next-generation Tablo hemodialysis system has received 510(k) clearance, marking a key regulatory milestone for the company. The clearance positions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results